2012 Chemotactic Cytokines Gordon Research Conference & Gordon Research Seminar
2012 Chemotactic Cytokines Gordon Research Conference & Gordon Research Seminar
批准号:
8307657
负责人:
ANDREW D LUSTER
金额:
$0.7万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-03-01 至 2013-02-28
关键词:
AffectAgeAge-YearsAmericanAreaAutoimmune DiseasesAutoimmunityBiochemicalBiologicalBrainCell CommunicationCellsChemotactic FactorsClinicClinical ResearchCollaborationsCommunicable DiseasesComplexCountryCytokine GeneDevelopmentDisciplineDiseaseEmbryonic DevelopmentEmigrationsEnsureEnvironmentEuropeFeedbackFeesFertilizationFosteringFutureFuture GenerationsGene FamilyGenerationsGoalsGrowthHealthHost DefenseHumanHuman GenomeImmuneInflammationInflammatoryInterventionJournalsLeukocytesLinkMalignant NeoplasmsMedicalMentorsMolecularNeoplasm MetastasisOralOrganParticipantPathogenesisPathologic ProcessesPathologyPathway interactionsPhysiological ProcessesPlayPostdoctoral FellowRecording of previous eventsRequest for ApplicationsResearchResearch PersonnelResearch Project GrantsRoleScientistSeasonsSenior ScientistSeriesSignal TransductionSocial InteractionSpecialistTherapeuticThinkingTimeTissuesTranslationsTravelUnited States National Institutes of HealthWorkabstractingage groupbasecell typechemokinechemokine receptorempoweredexperiencegraduate studenthuman diseaseinnovationintercellular communicationmedical specialtiesmeetingsmigrationnovelnovel strategiespeerplanetary Atmospherepostersprofessorprogramsreceptorresearch studysymposiumtherapeutic targettumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chemokines, the structurally homologous, functionally distinct chemotactic cytokines together with their cognate classical and atypical receptors comprise a complex molecular network involved in nearly all aspects of human health and disease. The Gordon Research Conference (GRC) on Chemotactic Cytokines 2012 is a world premier meeting devoted entirely to understanding these important molecules. This will be our 10th Chemokine GRC, which has been held every other year since 1994, when chemokines first burst onto the scene as the largest cytokine gene family in the human genome. Similar to each preceding conference in this series, Chemokine GRC 2012 will bring together scientists from a broad range of biomedical disciplines to showcase the latest unpublished research findings that cover all aspects of chemokine function and provide a high-quality scientific forum to discuss their potential implications, including translation to the clinic. The program of this meeting will cover basic biochemical and biological aspects of chemokines as related to their contributions to leukocyte migration, emigration, immune tissue organization and function; the role of chemokines during inflammation, including infectious diseases and autoimmunity in distinct organs and tissues; and multifaceted contributions of chemokines to cancer pathogenesis. In addition, for the first time in the history of this conference, we will introduce he Gordon Research Seminars (GRS), a satellite meeting for bench scientists at the graduate and postdoctoral level. GRS will provide a forum where young researchers can present their work and receive feedback on their ongoing research projects from their peers and a selected panel of senior experts. GRS will promote grassroots level integration and networking within the field of chemokine research. We fully anticipate that the scientific discussions, research talks, poster sessions, and informal interactions between the participants of this conference will contribute to advancing our understanding of molecular mechanisms of chemokine involvement in disease pathogenesis. This will set the basis for the development of new collaborative projects leading to new discoveries and ultimately resulting in new therapies and approaches to treat debilitating human disease, including inflammatory and autoimmune diseases and cancer.
PUBLIC HEALTH RELEVANCE: The Gordon Research Conference on Chemotactic Cytokines and the Gordon Research Seminar will bring together chemokine scientists from a variety of biomedical disciplines at all levels of this endeavor, including established investigators, junior investigators, and future generations of chemokine researchers. Scientific presentations, discussions and poster sessions during this conference will expand our understanding of the mechanisms by which chemokines contribute to health and disease. It is anticipated that the collegial and cooperative atmosphere that has traditionally characterized these conferences will provide the perfect setting for the intellectual development, cross-fertilization and future collaborations that are so vital to keep this field at the forefront of scientific innovation and discovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Allergen-specific lung-resident Tregs in asthma: Targetable suppressors of resident memory Th2 cells
-
批准号:10563192
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2022
-
负责人:ANDREW D LUSTER
-
依托单位:
Allergen-specific lung-resident Tregs in asthma: Targetable suppressors of resident memory Th2 cells
-
批准号:10418189
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2022
-
负责人:ANDREW D LUSTER
-
依托单位:
Features of Broad T Cell Coronavirus Immunity
-
批准号:10842889
-
项目类别:
-
资助金额:$198.74万
-
财政年份:2021
-
负责人:ANDREW D LUSTER
-
依托单位:
Features of Broad T Cell Coronavirus Immunity
-
批准号:10328120
-
项目类别:
-
资助金额:$257.29万
-
财政年份:2021
-
负责人:ANDREW D LUSTER
-
依托单位:
The CXCR3 Chemokine System in Cancer Immunotherapy
-
批准号:10053710
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2016
-
负责人:ANDREW D LUSTER
-
依托单位:
2014 Chemotactic Cytokines Gordon Research Conference and Gordon Research Seminar
-
批准号:8708388
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2014
-
负责人:ANDREW D LUSTER
-
依托单位:
Administrative Core
-
批准号:8196493
-
项目类别:
-
资助金额:$14.56万
-
财政年份:2011
-
负责人:ANDREW D LUSTER
-
依托单位:
Linking allergen-specific T cell effector and regulatory responses to asthma
-
批准号:8196484
-
项目类别:
-
资助金额:$35.51万
-
财政年份:2011
-
负责人:ANDREW D LUSTER
-
依托单位:
T cell effector and regulatory mechanisms in asthma and food allergy
-
批准号:8707948
-
项目类别:
-
资助金额:$204.55万
-
财政年份:2011
-
负责人:ANDREW D LUSTER
-
依托单位:
T cell effector and regulatory mechanisms in asthma and food allergy
-
批准号:8165321
-
项目类别:
-
资助金额:$203.96万
-
财政年份:2011
-
负责人:ANDREW D LUSTER
-
依托单位:
T cell effector and regulatory mechanisms in asthma and food allergy
-
批准号:8516341
-
项目类别:
-
资助金额:$264.79万
-
财政年份:2011
-
负责人:ANDREW D LUSTER
-
依托单位:
T cell effector and regulatory mechanisms in asthma and food allergy
-
批准号:8311661
-
项目类别:
-
资助金额:$192.07万
-
财政年份:2011
-
负责人:ANDREW D LUSTER
-
依托单位:
Research Training in Allergy and Immunology at Massachusetts General Hospital
-
批准号:7787508
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2006
-
负责人:ANDREW D LUSTER
-
依托单位:
Research Training in Allergy and Immunology at Massachusetts General Hospital
-
批准号:7420988
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2006
-
负责人:ANDREW D LUSTER
-
依托单位:
Research Training in Allergy and Immunology at Massachusetts General Hospital
-
批准号:7123118
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2006
-
负责人:ANDREW D LUSTER
-
依托单位:
Research Training in Allergy and Immunology at Massachusetts General Hospital
-
批准号:7250883
-
项目类别:
-
资助金额:$17.66万
-
财政年份:2006
-
负责人:ANDREW D LUSTER
-
依托单位:
Research Training in Allergy and Immunology at Massachusetts General Hospital
-
批准号:7613377
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2006
-
负责人:ANDREW D LUSTER
-
依托单位:
Biochemical and Genetic Dissection of Chemokine Receptor CXCR3 Signaling
-
批准号:7651313
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2005
-
负责人:ANDREW D LUSTER
-
依托单位:
Conference--Chemokines and Chemokine Receptors
-
批准号:7001945
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2005
-
负责人:ANDREW D LUSTER
-
依托单位:
Biochemical and Genetic Dissection of Chemokine Receptor CXCR3 Signaling
-
批准号:7077496
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2005
-
负责人:ANDREW D LUSTER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: